Robert is driven by a vision of personalized medical decisions in disease treatment based on biomarkers and genetic variants. He believe that the use of genetic profiles and biomarkers to guide treatment choices is the future of pharmaceutical medical therapy and is in-line with the needs of patients, physicians, and payers.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)